Regulating biopharmaceuticals under CDER versus CBER: an insider's perspective. | NobleID

Main

Mint Work Search Explore Works Knowledge Graph Citation Graph Bibliometrics Receipts

v1

Regulating biopharmaceuticals under CDER versus CBER: an insider's perspective.

Identifier:nobleid.org/w1/20260515/AF24C84C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF24C84C.svg?ark=w1%2F20260515%2FAF24C84C)](https://nobleid.org/work/w1/20260515/AF24C84C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

William D Schwieterman

Claim authorship of this work

info@nobleid.org

About FAQ Terms Policy Persistence & Resolver Service Policy